Skip to content

Geron GERN Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Immunome logo
ImmunomeIMNM
$150K+30.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2M0.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$972K-4.0%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$529K+6.2%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's non-cash lease expense?
Geron (GERN) reported non-cash lease expense of $192K in Q1 2026.
How has Geron's non-cash lease expense changed year-over-year?
Geron's non-cash lease expense increased by 8.5% year-over-year, from $177K to $192K.
What is the long-term trend for Geron's non-cash lease expense?
Over 4 years (2021 to 2025), Geron's non-cash lease expense has grown at a 6.5% compound annual growth rate (CAGR), from $568K to $730K.
What does non-cash lease expense mean?
Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.